Deal Announced for New Multi-Room Proton Therapy Center in China
By MedImaging International staff writers Posted on 11 Jul 2016 |
Image: The ProteusPLUS proton therapy solution (Photo courtesy of IBA Proton Therapy).
A contract worth more than EUR 80 million has been signed for the installation of a new multi-room proton therapy center in a new cancer treatment center in Qingdao, Shandong Province, China.
The deal includes a fixed-beam treatment room, four isocentric-gantry treatment rooms, and a long-term operations and maintenance contract. The company will also provide all required dosimetry equipment for the center, which should be ready to treat patients by the end of 2018. The deal will also include adaptive intensity modulated proton-therapy pencil-beam scanning and Cone Beam Computer Tomography (CBCT).
The contract was awarded to IBA Proton Therapy (Louvain-La-Neuve, Belgium) by the Qingdao Zhong Jia Lian He healthcare management company (Qingdao, Shandong Province, China).
Wang Xiang Yu, of the Qingdao Zhong Jia Lian He company, said, “We want to have the most innovative treatments for our cancer patients in order to effectively fight this severe disease; proton therapy will help give our team of oncologists the critical tools to fight cancer. Our new ProteusPLUS multi-room solution, including Pencil Beam Scanning and Cone Beam CT technology, will be installed by IBA and will allow us to ‘paint’ tumors with a super-fine beam of protons, destroying cancer cells whilst leaving surrounding healthy tissue untouched.”
Related Links:
IBA Proton Therapy
The deal includes a fixed-beam treatment room, four isocentric-gantry treatment rooms, and a long-term operations and maintenance contract. The company will also provide all required dosimetry equipment for the center, which should be ready to treat patients by the end of 2018. The deal will also include adaptive intensity modulated proton-therapy pencil-beam scanning and Cone Beam Computer Tomography (CBCT).
The contract was awarded to IBA Proton Therapy (Louvain-La-Neuve, Belgium) by the Qingdao Zhong Jia Lian He healthcare management company (Qingdao, Shandong Province, China).
Wang Xiang Yu, of the Qingdao Zhong Jia Lian He company, said, “We want to have the most innovative treatments for our cancer patients in order to effectively fight this severe disease; proton therapy will help give our team of oncologists the critical tools to fight cancer. Our new ProteusPLUS multi-room solution, including Pencil Beam Scanning and Cone Beam CT technology, will be installed by IBA and will allow us to ‘paint’ tumors with a super-fine beam of protons, destroying cancer cells whilst leaving surrounding healthy tissue untouched.”
Related Links:
IBA Proton Therapy
Latest Industry News News
- Hologic Acquires UK-Based Breast Surgical Guidance Company Endomagnetics Ltd.
- Bayer and Google Partner on New AI Product for Radiologists
- Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement
- IBA Acquires Radcal to Expand Medical Imaging Quality Assurance Offering
- International Societies Suggest Key Considerations for AI Radiology Tools
- Samsung's X-Ray Devices to Be Powered by Lunit AI Solutions for Advanced Chest Screening
- Canon Medical and Olympus Collaborate on Endoscopic Ultrasound Systems
- GE HealthCare Acquires AI Imaging Analysis Company MIM Software
- First Ever International Criteria Lays Foundation for Improved Diagnostic Imaging of Brain Tumors
- RSNA Unveils 10 Most Cited Radiology Studies of 2023
- RSNA 2023 Technical Exhibits to Offer Innovations in AI, 3D Printing and More
- AI Medical Imaging Products to Increase Five-Fold by 2035, Finds Study
- RSNA 2023 Technical Exhibits to Highlight Latest Medical Imaging Innovations
- AI-Powered Technologies to Aid Interpretation of X-Ray and MRI Images for Improved Disease Diagnosis
- Hologic and Bayer Partner to Improve Mammography Imaging
- Global Fixed and Mobile C-Arms Market Driven by Increasing Surgical Procedures